1 Introduction to Research & Analysis Reports
1.1 Castration-resistant Prostate Cancer Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Castration-resistant Prostate Cancer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Castration-resistant Prostate Cancer Drugs Overall Market Size
2.1 Global Castration-resistant Prostate Cancer Drugs Market Size: 2022 VS 2029
2.2 Global Castration-resistant Prostate Cancer Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Castration-resistant Prostate Cancer Drugs Players in Global Market
3.2 Top Global Castration-resistant Prostate Cancer Drugs Companies Ranked by Revenue
3.3 Global Castration-resistant Prostate Cancer Drugs Revenue by Companies
3.4 Top 3 and Top 5 Castration-resistant Prostate Cancer Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Castration-resistant Prostate Cancer Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Castration-resistant Prostate Cancer Drugs Players in Global Market
3.6.1 List of Global Tier 1 Castration-resistant Prostate Cancer Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Castration-resistant Prostate Cancer Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Castration-resistant Prostate Cancer Drugs Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Intravenous Injection
4.1.4 Others
4.2 By Type – Global Castration-resistant Prostate Cancer Drugs Revenue & Forecasts
4.2.1 By Type – Global Castration-resistant Prostate Cancer Drugs Revenue, 2018-2023
4.2.2 By Type – Global Castration-resistant Prostate Cancer Drugs Revenue, 2024-2029
4.2.3 By Type – Global Castration-resistant Prostate Cancer Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Castration-resistant Prostate Cancer Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Specialty Clinic
5.1.4 Others
5.2 By Application – Global Castration-resistant Prostate Cancer Drugs Revenue & Forecasts
5.2.1 By Application – Global Castration-resistant Prostate Cancer Drugs Revenue, 2018-2023
5.2.2 By Application – Global Castration-resistant Prostate Cancer Drugs Revenue, 2024-2029
5.2.3 By Application – Global Castration-resistant Prostate Cancer Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Castration-resistant Prostate Cancer Drugs Market Size, 2022 & 2029
6.2 By Region – Global Castration-resistant Prostate Cancer Drugs Revenue & Forecasts
6.2.1 By Region – Global Castration-resistant Prostate Cancer Drugs Revenue, 2018-2023
6.2.2 By Region – Global Castration-resistant Prostate Cancer Drugs Revenue, 2024-2029
6.2.3 By Region – Global Castration-resistant Prostate Cancer Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Castration-resistant Prostate Cancer Drugs Revenue, 2018-2029
6.3.2 US Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.3.3 Canada Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.3.4 Mexico Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Castration-resistant Prostate Cancer Drugs Revenue, 2018-2029
6.4.2 Germany Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.4.3 France Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.4.4 U.K. Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.4.5 Italy Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.4.6 Russia Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.4.8 Benelux Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Castration-resistant Prostate Cancer Drugs Revenue, 2018-2029
6.5.2 China Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.5.3 Japan Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.5.4 South Korea Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.5.6 India Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Castration-resistant Prostate Cancer Drugs Revenue, 2018-2029
6.6.2 Brazil Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.6.3 Argentina Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Castration-resistant Prostate Cancer Drugs Revenue, 2018-2029
6.7.2 Turkey Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.7.3 Israel Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
6.7.5 UAE Castration-resistant Prostate Cancer Drugs Market Size, 2018-2029
7 Castration-resistant Prostate Cancer Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Castration-resistant Prostate Cancer Drugs Major Product Offerings
7.1.4 Pfizer Castration-resistant Prostate Cancer Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Astellas
7.2.1 Astellas Company Summary
7.2.2 Astellas Business Overview
7.2.3 Astellas Castration-resistant Prostate Cancer Drugs Major Product Offerings
7.2.4 Astellas Castration-resistant Prostate Cancer Drugs Revenue in Global Market (2018-2023)
7.2.5 Astellas Key News & Latest Developments
7.3 Janssen
7.3.1 Janssen Company Summary
7.3.2 Janssen Business Overview
7.3.3 Janssen Castration-resistant Prostate Cancer Drugs Major Product Offerings
7.3.4 Janssen Castration-resistant Prostate Cancer Drugs Revenue in Global Market (2018-2023)
7.3.5 Janssen Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Castration-resistant Prostate Cancer Drugs Major Product Offerings
7.4.4 AstraZeneca Castration-resistant Prostate Cancer Drugs Revenue in Global Market (2018-2023)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Castration-resistant Prostate Cancer Drugs Major Product Offerings
7.5.4 Bayer Castration-resistant Prostate Cancer Drugs Revenue in Global Market (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Hengrui
7.6.1 Hengrui Company Summary
7.6.2 Hengrui Business Overview
7.6.3 Hengrui Castration-resistant Prostate Cancer Drugs Major Product Offerings
7.6.4 Hengrui Castration-resistant Prostate Cancer Drugs Revenue in Global Market (2018-2023)
7.6.5 Hengrui Key News & Latest Developments
7.7 CTTQ
7.7.1 CTTQ Company Summary
7.7.2 CTTQ Business Overview
7.7.3 CTTQ Castration-resistant Prostate Cancer Drugs Major Product Offerings
7.7.4 CTTQ Castration-resistant Prostate Cancer Drugs Revenue in Global Market (2018-2023)
7.7.5 CTTQ Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Castration-resistant Prostate Cancer Drugs Major Product Offerings
7.8.4 Sanofi Castration-resistant Prostate Cancer Drugs Revenue in Global Market (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
7.9 Hansoh
7.9.1 Hansoh Company Summary
7.9.2 Hansoh Business Overview
7.9.3 Hansoh Castration-resistant Prostate Cancer Drugs Major Product Offerings
7.9.4 Hansoh Castration-resistant Prostate Cancer Drugs Revenue in Global Market (2018-2023)
7.9.5 Hansoh Key News & Latest Developments
7.10 Clovis Oncology
7.10.1 Clovis Oncology Company Summary
7.10.2 Clovis Oncology Business Overview
7.10.3 Clovis Oncology Castration-resistant Prostate Cancer Drugs Major Product Offerings
7.10.4 Clovis Oncology Castration-resistant Prostate Cancer Drugs Revenue in Global Market (2018-2023)
7.10.5 Clovis Oncology Key News & Latest Developments
7.11 Zhendong Pharmaceutical
7.11.1 Zhendong Pharmaceutical Company Summary
7.11.2 Zhendong Pharmaceutical Business Overview
7.11.3 Zhendong Pharmaceutical Castration-resistant Prostate Cancer Drugs Major Product Offerings
7.11.4 Zhendong Pharmaceutical Castration-resistant Prostate Cancer Drugs Revenue in Global Market (2018-2023)
7.11.5 Zhendong Pharmaceutical Key News & Latest Developments
7.12 Merck
7.12.1 Merck Company Summary
7.12.2 Merck Business Overview
7.12.3 Merck Castration-resistant Prostate Cancer Drugs Major Product Offerings
7.12.4 Merck Castration-resistant Prostate Cancer Drugs Revenue in Global Market (2018-2023)
7.12.5 Merck Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Table 1. Castration-resistant Prostate Cancer Drugs Market Opportunities & Trends in Global Market
Table 2. Castration-resistant Prostate Cancer Drugs Market Drivers in Global Market
Table 3. Castration-resistant Prostate Cancer Drugs Market Restraints in Global Market
Table 4. Key Players of Castration-resistant Prostate Cancer Drugs in Global Market
Table 5. Top Castration-resistant Prostate Cancer Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Castration-resistant Prostate Cancer Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Castration-resistant Prostate Cancer Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Castration-resistant Prostate Cancer Drugs Product Type
Table 9. List of Global Tier 1 Castration-resistant Prostate Cancer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Castration-resistant Prostate Cancer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Castration-resistant Prostate Cancer Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Castration-resistant Prostate Cancer Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Castration-resistant Prostate Cancer Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Castration-resistant Prostate Cancer Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Castration-resistant Prostate Cancer Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Castration-resistant Prostate Cancer Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Castration-resistant Prostate Cancer Drugs Product Offerings
Table 32. Pfizer Castration-resistant Prostate Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Astellas Company Summary
Table 35. Astellas Castration-resistant Prostate Cancer Drugs Product Offerings
Table 36. Astellas Castration-resistant Prostate Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Astellas Key News & Latest Developments
Table 38. Janssen Company Summary
Table 39. Janssen Castration-resistant Prostate Cancer Drugs Product Offerings
Table 40. Janssen Castration-resistant Prostate Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Janssen Key News & Latest Developments
Table 42. AstraZeneca Company Summary
Table 43. AstraZeneca Castration-resistant Prostate Cancer Drugs Product Offerings
Table 44. AstraZeneca Castration-resistant Prostate Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. AstraZeneca Key News & Latest Developments
Table 46. Bayer Company Summary
Table 47. Bayer Castration-resistant Prostate Cancer Drugs Product Offerings
Table 48. Bayer Castration-resistant Prostate Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Bayer Key News & Latest Developments
Table 50. Hengrui Company Summary
Table 51. Hengrui Castration-resistant Prostate Cancer Drugs Product Offerings
Table 52. Hengrui Castration-resistant Prostate Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Hengrui Key News & Latest Developments
Table 54. CTTQ Company Summary
Table 55. CTTQ Castration-resistant Prostate Cancer Drugs Product Offerings
Table 56. CTTQ Castration-resistant Prostate Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. CTTQ Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Castration-resistant Prostate Cancer Drugs Product Offerings
Table 60. Sanofi Castration-resistant Prostate Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Hansoh Company Summary
Table 63. Hansoh Castration-resistant Prostate Cancer Drugs Product Offerings
Table 64. Hansoh Castration-resistant Prostate Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Hansoh Key News & Latest Developments
Table 66. Clovis Oncology Company Summary
Table 67. Clovis Oncology Castration-resistant Prostate Cancer Drugs Product Offerings
Table 68. Clovis Oncology Castration-resistant Prostate Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Clovis Oncology Key News & Latest Developments
Table 70. Zhendong Pharmaceutical Company Summary
Table 71. Zhendong Pharmaceutical Castration-resistant Prostate Cancer Drugs Product Offerings
Table 72. Zhendong Pharmaceutical Castration-resistant Prostate Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Zhendong Pharmaceutical Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Castration-resistant Prostate Cancer Drugs Product Offerings
Table 76. Merck Castration-resistant Prostate Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Merck Key News & Latest Developments
List of Figures
Figure 1. Castration-resistant Prostate Cancer Drugs Segment by Type in 2022
Figure 2. Castration-resistant Prostate Cancer Drugs Segment by Application in 2022
Figure 3. Global Castration-resistant Prostate Cancer Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Castration-resistant Prostate Cancer Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Castration-resistant Prostate Cancer Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Castration-resistant Prostate Cancer Drugs Revenue in 2022
Figure 8. By Type - Global Castration-resistant Prostate Cancer Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Castration-resistant Prostate Cancer Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Castration-resistant Prostate Cancer Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Castration-resistant Prostate Cancer Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Castration-resistant Prostate Cancer Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Castration-resistant Prostate Cancer Drugs Revenue Market Share, 2018-2029
Figure 16. US Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Castration-resistant Prostate Cancer Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Castration-resistant Prostate Cancer Drugs Revenue Market Share, 2018-2029
Figure 28. China Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Castration-resistant Prostate Cancer Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Castration-resistant Prostate Cancer Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Castration-resistant Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Castration-resistant Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Astellas Castration-resistant Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Janssen Castration-resistant Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AstraZeneca Castration-resistant Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bayer Castration-resistant Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Hengrui Castration-resistant Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. CTTQ Castration-resistant Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sanofi Castration-resistant Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Hansoh Castration-resistant Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Clovis Oncology Castration-resistant Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Zhendong Pharmaceutical Castration-resistant Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Merck Castration-resistant Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
